Stefan Limmer
28Patents
12h-index
16Co-inventors
74Inventor score
Filing activity: Oct 31, 2002 → Jun 11, 2015
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US7829693B2 | Compositions and methods for inhibiting expression of a target gene | Chemistry; Metallurgy | 108 | Active |
| US7786290B2 | Double-stranded ribonucleic acid with increased effectiveness in an organism | Chemistry; Metallurgy | 92 | Active |
| US8101584B2 | Method and medicament for inhibiting the expression of a given gene | Emerging Cross-Sectional Technologies | 49 | Expired |
| US8546143B2 | Compositions and methods for inhibiting expression of a target gene | Chemistry; Metallurgy | 44 | Active |
| US7473525B2 | Compositions and methods for inhibiting expression of anti-apoptotic genes | Chemistry; Metallurgy | 30 | Expired |
| US7348314B2 | Compositions and methods for inhibiting viral replication | Chemistry; Metallurgy | 27 | Expired |
| US7700572B2 | SMAD7 inhibitors for the treatment of CNS diseases | Chemistry; Metallurgy | 25 | Expired |
| US7196184B2 | Double-stranded RNA (DSRNA) and method of use for inhibiting expression of the AML-1/MTG8 fusion gene | Chemistry; Metallurgy | 20 | Expired |
| US8101742B2 | Method and medicament for inhibiting the expression of a given gene | Chemistry; Metallurgy | 18 | Active |
| US7763590B2 | Compositions and methods for inhibiting expression of a mutant gene | Chemistry; Metallurgy | 14 | Expired |
| US8168776B2 | Method for making a 21 nucleotide double stranded RNA chemically linked at one end | Emerging Cross-Sectional Technologies | 12 | Expired |
| US8202980B2 | Method and medicament for inhibiting the expression of a given gene | Emerging Cross-Sectional Technologies | 12 | Expired |
| US8119608B2 | Method and medicament for inhibiting the expression of a given gene | Emerging Cross-Sectional Technologies | 10 | Expired |
| US8114851B2 | Method and medicament for inhibiting the expression of a given gene | Emerging Cross-Sectional Technologies | 9 | Active |
| US8114981B2 | Method and medicament for inhibiting the expression of a given gene | Emerging Cross-Sectional Technologies | 6 | Active |
| US8183362B2 | Method and medicament for inhibiting the expression of a given gene | Emerging Cross-Sectional Technologies | 6 | Active |
| US8273870B2 | Compositions and methods for inhibiting expression of a mutant gene | Chemistry; Metallurgy | 5 | Active |
| US7994309B2 | Compositions and methods for inhibiting expression of a mutant gene | Chemistry; Metallurgy | 5 | Active |
| US7846907B2 | Double-stranded RNA (dsRNA) and method of use for inhibiting expression of a fusion gene | Chemistry; Metallurgy | 5 | Active |
| US8273868B2 | Compositions and methods for inhibiting viral replication | Chemistry; Metallurgy | 5 | Active |
| US7745418B2 | Compositions and methods for inhibiting viral replication | Chemistry; Metallurgy | 4 | Active |
| US8877726B2 | Method and medicament for inhibiting the expression of a given gene | Emerging Cross-Sectional Technologies | 3 | Active |
| US9133454B2 | Method and medicament for inhibiting the expression of a given gene | Emerging Cross-Sectional Technologies | 2 | Active |
| US9074213B2 | Compositions and methods for inhibiting expression of a target gene | Chemistry; Metallurgy | 1 | Active |
| US8729037B2 | Method and medicament for inhibiting the expression of a given gene | Emerging Cross-Sectional Technologies | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.